AbbVie Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
285 result(s) found, displaying 21 to 30
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Australian Public Assessment Report (AusPAR)Rinvoq (upadacitinib) was approved for the treatment of active non-radiographic axial spondyloarthritis in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial.
-
Jul-2024Prescription medicine evaluationActive ingredient: Botulinim toxin type a.
-
Cancellation by sponsorRequested by Abbvie Pty Ltd